ESC 2008: "Real-world" study backs Biosensors' DES
This article was originally published in Clinica
Executive Summary
BioMatrix, the drug-eluting stent (DES) developed by Biosensors, has matched the efficacy of rival device Cypher, in a non-inferiority trial described by the firm's president as "risky".